Category: Latest News

  • Stevanato Group shares jump nearly 17% after strong fourth-quarter results

    Stevanato Group shares jump nearly 17% after strong fourth-quarter results

    Stevanato Group S.p.A. (NYSE:STVN) reported fourth-quarter results on Wednesday that came in ahead of analyst expectations. Shares of the company surged 16.70% in after-hours trading following the announcement, as investors responded to continued strength in its high-value solutions segment. The Italian provider of drug containment and delivery systems reported adjusted diluted earnings per share of…

  • Ascent Industries shares drop after reporting fourth-quarter loss

    Ascent Industries shares drop after reporting fourth-quarter loss

    Shares of Ascent Industries (NASDAQ:ACNT) fell 14.38% to $14.88 in premarket trading on Wednesday after the company reported a loss for the fourth quarter. The company recorded a net loss of $1 million for the quarter, compared with a profit of nearly $200,000 in the same period a year earlier. Chief Executive Officer Bryan Kitchen…

  • National Vision tops Q4 expectations, shares dip on cautious outlook

    National Vision tops Q4 expectations, shares dip on cautious outlook

    National Vision Holdings, Inc. (NASDAQ:EYE) reported fourth-quarter results on Wednesday that came in above analyst forecasts. Despite the stronger-than-expected performance, the company’s shares fell 1.09% in premarket trading as investors evaluated the retailer’s fiscal 2026 guidance relative to market expectations. The optical retailer reported adjusted earnings per share of $0.15 for the quarter, surpassing the…

  • CrowdStrike tops Q4 expectations, provides steady outlook for fiscal 2027

    CrowdStrike tops Q4 expectations, provides steady outlook for fiscal 2027

    CrowdStrike (NASDAQ:CRWD) reported fourth-quarter results that exceeded Wall Street forecasts and issued guidance for fiscal 2027 that was broadly in line with market expectations, as investors continue to assess the impact of artificial intelligence on the software sector. Shares of the cybersecurity company rose 1.4% in U.S. premarket trading on Wednesday. The stock has declined…

  • Wix.com matches Q4 revenue expectations, forecasts mid-teens growth for 2026

    Wix.com matches Q4 revenue expectations, forecasts mid-teens growth for 2026

    Wix.com (NASDAQ:WIX) reported fourth-quarter revenue of $524.3 million, up 14% from a year earlier and broadly in line with analysts’ average estimate of $527.9 million, according to Bloomberg consensus data. The company posted non-GAAP operating income of $81.2 million for the quarter, exceeding the $77.1 million analysts had expected. Adjusted gross profit reached $358.8 million,…

  • GitLab shares slide after disappointing earnings guidance

    GitLab shares slide after disappointing earnings guidance

    Shares of GitLab (NASDAQ:GTLB) dropped 8.8% to $24.35 in premarket trading on Wednesday after the software development platform issued a fiscal 2027 earnings outlook that came in below Wall Street expectations. The company forecast adjusted earnings per share of between 76 cents and 80 cents for fiscal 2027, well under analysts’ consensus estimate of $1.05,…

  • Moderna agrees up to $2.25 billion settlement in COVID vaccine patent dispute

    Moderna agrees up to $2.25 billion settlement in COVID vaccine patent dispute

    Moderna (NASDAQ:MRNA) has reached a settlement worth up to $2.25 billion with Genevant Sciences, a subsidiary of Roivant Sciences (NASDAQ:ROIV), and Arbutus Biopharma (NASDAQ:ABUS), resolving a patent dispute tied to its COVID-19 vaccine. The agreement brings to an end multiple legal cases in the United States and internationally that alleged Moderna used lipid nanoparticle (LNP)…

  • Novo Nordisk gains after FDA issues warnings to telehealth firms over compounded GLP-1 drugs

    Novo Nordisk gains after FDA issues warnings to telehealth firms over compounded GLP-1 drugs

    Shares of Novo Nordisk (NYSE:NVO) climbed more than 3% on Wednesday after the U.S. Food and Drug Administration sent warning letters to 30 telehealth companies over false or misleading marketing of compounded GLP-1 medications, including versions of the company’s semaglutide and Eli Lilly’s tirzepatide. According to the FDA, the companies breached regulations by promoting compounded…

  • Latham Group shares climb after stronger-than-expected quarterly sales

    Latham Group shares climb after stronger-than-expected quarterly sales

    Shares of Latham Group (NASDAQ:SWIM) surged 19.6% to $7.76 in premarket trading on Wednesday after the swimming pool manufacturer posted fourth-quarter results that came in ahead of analysts’ forecasts. The company reported that net sales for the quarter rose 14.5% compared with the same period a year earlier. Latham Group also highlighted particularly strong performance…

  • Oil jumps as Middle East conflict raises supply concerns; Goldman upgrades outlook

    Oil jumps as Middle East conflict raises supply concerns; Goldman upgrades outlook

    Oil prices climbed sharply on Wednesday, extending strong gains from the previous two sessions as the escalating conflict involving the United States, Israel, and Iran heightened fears of disruptions to global crude supply. At 03:40 ET (08:40 GMT), Brent crude futures for May delivery were up 3.5% at $84.25 per barrel, while U.S. West Texas…